The most active compound AK‐2292 effectively induced degradation of STAT5A, STAT5B, and phosphorylated STAT5 proteins in AML cells in a concentration‐ and time‐dependent manner, and exhibited excellent degradation selectivity for STAT5 over all other STAT members. This evidence concerns the gene STAT5A and acute myeloid leukemia.